Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein(a) levels by more than 90% for at least six months with a single injection in a phase 2 trial, reinforcing its ...

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...

This profile has not been claimed by the company. See reviews below to learn more or submit your own review. H&R Block is a tax preparation and financial services company that has been providing its ...

Top stocks in which highest number of deals(bulk & block) were seen over a period of time in terms of deal value or count(bulk & block). Top Investors in order of ...

The transaction, completed on behalf of Galaxy, which also acted as the structurer, marks one of the first debt issuances ever executed on a public blockchain Coinbase was the lead investor, alongside ...

J.P. Morgan announced today that it has successfully arranged a U.S. Commercial Paper (‘USCP’) issuance for Galaxy Digital Holdings LP, an affiliate of Galaxy Inc. (‘Galaxy’) on Solana, purchased by ...

The transaction, completed on behalf of Galaxy, which also acted as the structurer, marks one of the first debt issuances ever executed on a public blockchain Coinbase was the lead investor, alongside ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...